AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 111 filers reported holding AKERO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 8.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,155,720 | +358.4% | 42,620 | +323.1% | 0.05% | +350.0% |
| Q2 2023 | $470,308 | -62.4% | 10,073 | -55.9% | 0.01% | -65.7% |
| Q4 2022 | $1,251,084 | -10.8% | 22,830 | -44.5% | 0.04% | -28.6% |
| Q3 2022 | $1,402,000 | +749.7% | 41,167 | +135.1% | 0.05% | +600.0% |
| Q2 2022 | $165,000 | -2.4% | 17,509 | +46.9% | 0.01% | -12.5% |
| Q1 2022 | $169,000 | -30.2% | 11,916 | +42.8% | 0.01% | -63.6% |
| Q1 2021 | $242,000 | +11.0% | 8,343 | -1.3% | 0.02% | -4.3% |
| Q4 2020 | $218,000 | +7.9% | 8,452 | +28.7% | 0.02% | +76.9% |
| Q3 2020 | $202,000 | – | 6,568 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |